Carisma Therapeutics Inc. Insider Trading

CARM

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

None

in the last two years

Get an email when CARM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 7, 2025	Michael Klichinsky Chief Scientific Officer	SoldNo plan	56,982	$0.25	14K	100%	Form 4
Oct 1, 2025 – Oct 3, 2025	Michael Klichinsky Chief Scientific Officer	SoldNo plan 3 parts	484,347	$0.26 average	124K	100%	Form 4

Oct 7, 2025No plan
Michael Klichinsky
Chief Scientific Officer · sold 56,982 at $0.25
14K
100% of stake
Oct 1, 2025 – Oct 3, 2025No plan
Michael Klichinsky
Chief Scientific Officer · sold 484,347 at avg $0.26
124K
100% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CARM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CARM

CompareIntrinsic value

OCULOcular Therapeutix Inc.

$7.14+4.69%10

GOSSGossamer Bio Inc.

$9.40+1.29%10

SIGASiga Technologies Inc.

$3.15+1.29%20

QTTBQ32 Bio Inc.

$8.97+2.40%60

TNGXTango Therapeutics Inc.

$23.18+0.04%40

AQSTAquestive Therapeutics Inc.

$3.80-2.06%10

PRTAProthena Corporation plc

$8.39+2.19%25

NKTRNektar Therapeutics Inc.

$38.48+1.91%25

Held by ETFs

CARM is in 1 US ETF. The largest of them, with CARM's weight in each:

Fidelity Enhanced Small Cap ETFFESM0.00%of the fund

Spot a number that looks wrong? Check it in CARM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CARM

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.